Literature DB >> 11483867

Prohemorrhagic potential of dipyrone, ibuprofen, ketorolac, and aspirin: mechanisms associated with blood flow and erythrocyte deformability.

J Bozzo1, G Escolar, M R Hernández, A M Galán, A Ordinas.   

Abstract

Dipyrone, ibuprofen, ketorolac, and aspirin were tested in a well-defined perfusion system (shear rates: 300/s, 800/s, and 1,800/s). Whole blood samples were treated with the drugs at analgesic doses and platelet interaction with damaged subendothelium was measured. All the drugs fully inhibited platelet cyclooxygenase, as assessed by classic aggregometry. Perfusion studies showed that there was a general tendency to reduce the percentage of large aggregates (thrombus; %T), to increase the percentage of adhered platelets (adhesion; %A), and to reduce the height of thrombi with respect to control. Aspirin significantly increased %A and reduced %T at all shear rates tested, whereas dipyrone had the same effect at 800/s, and ketorolac and ibuprofen at 1,800/s. In addition, aspirin significantly reduced erythrocyte deformability with respect to the other drugs. In conclusion, under our experimental conditions, aspirin showed the most remarkable effects on platelet function, closely followed by dipyrone. The effects of ketorolac were moderate, whereas ibuprofen had a minor impact on platelet function.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11483867     DOI: 10.1097/00005344-200108000-00003

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  6 in total

Review 1.  Impact of drugs on venous thromboembolism risk in surgical patients.

Authors:  Alenka Premuš Marušič Kovačič; Martin Caprnda; Aleš Mrhar; Peter Kubatka; Igor Locatelli; Barbora Zolakova; Ludovit Gaspar; Robert Prosecky; Peter Kruzliak; Robert Staffa; Luis Rodrigo; Jozef Radonak; Danijel Petrovič
Journal:  Eur J Clin Pharmacol       Date:  2019-02-05       Impact factor: 2.953

2.  A randomized, double-blind crossover trial of paracetamol 1000 mg four times daily vs ibuprofen 600 mg: effect on swelling and other postoperative events after third molar surgery.

Authors:  G A Bjørnsson; H R Haanaes; L A Skoglund
Journal:  Br J Clin Pharmacol       Date:  2003-04       Impact factor: 4.335

3.  Impaired Erythrocyte Deformability in Patients with Coronary Risk Factors: Significance of Nonvalvular Atrial Fibrillation.

Authors:  Keita Odashiro; Toru Maruyama; Taku Yokoyama; Hisataka Nakamura; Mitsuhiro Fukata; Shioto Yasuda; Kazuyuki Saito; Takehiko Fujino; Koichi Akashi
Journal:  J Atr Fibrillation       Date:  2013-10-31

4.  Effects of lornoxicam and intravenous ibuprofen on erythrocyte deformability and hepatic and renal blood flow in rats.

Authors:  Hande Arpacı; Faruk Metin Çomu; Ayşegül Küçük; Bahadır Kösem; Seyfi Kartal; Volkan Şıvgın; Hüseyin Cihad Turgut; Muhammed Enes Aydın; Derya Sebile Koç; Mustafa Arslan
Journal:  Drug Des Devel Ther       Date:  2016-08-03       Impact factor: 4.162

5.  Isolation of megakaryocytes using magnetic cell separation and adverse effects induced by diclofenac toxicity in an experiment.

Authors:  Irina Yuriivna Bagmut; Olexiy Sergiyovych Ivanov; Michael Ivanovich Sheremet; Sergiy Mykolayovych Smirnov; Igor Leonidovich Kolisnyk; Julia Viktorivna Ivanova; Mykhailo Yevgenievich Tymchenko; Vyacheslav Oleksievich Lazirskiy
Journal:  J Med Life       Date:  2022-01

6.  Lack of influence of the COX inhibitors metamizol and diclofenac on platelet GPIIb/IIIa and P-selectin expression in vitro.

Authors:  Dirk Scheinichen; Holger-Andreas Elsner; Rodin Osorio; Björn Jüttner; Werner Gröschel; Karsten Jaeger; Siegfried Piepenbrock
Journal:  BMC Anesthesiol       Date:  2004-04-23       Impact factor: 2.217

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.